RxDoctor Payments Data

Courtney Miles

Psychiatric/Mental Health · Festus, MONPI 1558921296

Payments from drug & device makers

$3,155in general payments, 2019–2025

Across 174 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$548
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$440
  • Neurocrine Biosciences, Inc.$274
  • Lundbeck LLC$274
  • Johnson & Johnson$198
  • Otsuka America Pharmaceutical, Inc.$197
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$3,10899%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,155 in reported general payments places this provider in the 80th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$13,305
Medicare patients
30
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl55$84,474
RexultiBrexpiprazole18$33,596
Aripiprazole35$4,350
Trazodone Hcl176$3,540
Clozapine29$3,400
Oxcarbazepine12$2,521
Ziprasidone Hcl41$2,279
Quetiapine Fumarate118$2,201
Duloxetine Hcl97$2,101
Modafinil20$1,328
Bupropion XlBupropion Hcl59$1,134
Clonazepam134$1,007
Prazosin Hcl31$981
Fluoxetine Hcl80$931
Doxepin Hcl17$869

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$548$84,47455 claims
Otsuka America Pharmaceutical, Inc.Rexulti$197$33,59618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Festus

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →